Genhouse Bio is a Suzhou-based biopharmaceutical company discovering and developing targeted oncology therapeutics
Genhouse Bio is a Suzhou-based biopharmaceutical company discovering and developing targeted oncology therapeutics. Its in-house pipeline focuses on the Ras-MAPK signaling pathway and synthetic lethality, supported by integrated structural biology, drug discovery and design, druggability evaluation, and translational medicine platforms. The company develops small-molecule drug candidates and has candidates in clinical and preclinical stages, with licensing and collaboration deals including Gile.